250 results on '"Quadrio, Isabelle"'
Search Results
2. Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort study
3. Comparative diagnosis interest of NfL and pNfH in CSF and plasma in a context of FTD–ALS spectrum
4. Proteinopathies associated to repeat expansion disorders
5. Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis
6. Functional and Molecular Characterization of New SPTLC1 Missense Variants in Patients with Hereditary Sensory and Autonomic Neuropathy Type 1 (HSAN1)
7. Identification of rare variants in the FBXO38 gene of patients with chronic inflammatory demyelinating polyradiculoneuropathy
8. Place de la biologie dans les maladies de Creutzfeldt-Jakob et apparentées
9. Marqueurs biologiques et maladie d’Alzheimer
10. An automated alert system based on the p-Tau/Tau ratio to quickly inform health professionals upon a suspected case of sporadic Creutzfeldt-Jakob disease.
11. PSP‐Richardson's Syndrome as a Rare Phenotypic Expression of Very Late‐Onset Huntington's Disease: A Case Report
12. The standardization of cerebrospinal fluid markers and neuropathological diagnoses brings to light the frequent complexity of concomitant pathology in Alzheimer's disease: The next challenge for biochemical markers?
13. A previously unreported NARS1 variant causes dominant distal hereditary motor neuropathy in a French family.
14. Prospective 25-year surveillance of prion diseases in France, 1992 to 2016: a slow waning of epidemics and an increase in observed sporadic forms
15. Correspondence on ‘Neurofilament light chain as a biomarker of neuronal damage in children with malaria’
16. Isotopic Evidence for Disrupted Copper Metabolism in Amyotrophic Lateral Sclerosis
17. TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration
18. Isolated seizures are a common early feature of paraneoplastic anti-GABAB receptor encephalitis
19. Development of an automated capillary nano-immunoassay—Simple Western assay—to quantify total TDP43 protein in human platelet samples
20. Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability
21. Neurofilaments contribution in clinic: state of the art
22. Neopterin level can be measured by intraocular liquid biopsy
23. CSF biomarker variability in the Alzheimer's Association quality control program
24. Modeling Neurodegenerative Diseases Using In Vitro Compartmentalized Microfluidic Devices
25. The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study
26. Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes
27. Analytical validation of microdialysis analyzer for monitoring glucose, lactate and pyruvate in cerebral microdialysates
28. Charge detection mass spectrometry on human-amplified fibrils from different synucleinopathies
29. Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid
30. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
31. Association of Cerebrospinal Fluid Prion Protein Levels and the Distinction Between Alzheimer Disease and Creutzfeldt-Jakob Disease
32. Rapid diagnosis of human prion disease using streptomycin with tonsil and brain tissues
33. Comparative diagnosis interest of NfL and pNfH in CSF and plasma in a context of FTD–ALS spectrum
34. Oral transmission of L-type bovine spongiform encephalopathy in primate model
35. Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy
36. Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis
37. Les neurofilaments : un nouveau biomarqueur clé pour les cliniciens. Partie 2 : Neurofilaments, un intérêt au-delà des maladies neurodégénératives.
38. Les neurofilaments : un nouveau biomarqueur clé pour les cliniciens. Partie 1 : Intérêt des neurofilaments dans la prise en charge des maladies neurodégénératives.
39. Prion potentiation after life-long dormancy in mice devoid of PrP
40. International initiative for harmonization of cerebrospinal fluid diagnostic comments in Alzheimer's disease
41. Pre-Analytical and Analytical Critical Factors Influencing the High Variability of the Concentrations Levels of Alzheimer Disease Biomarkers in Cerebral Spinal Fluid
42. Diagnostic du syndrome CANVAS : indications privilégiées et résultats du diagnostic moléculaire à partir de 73 cas diagnostiqués dans le Rhône (2019–2022)
43. Intérêt des neurofilaments et de la neuropentraxine 2 dans l’exploration biologique des encéphalites dysimmunes
44. Développement d’une méthode de détection des alpha-synucléinopathies par technologie RT-QuIC (Real Time-Quaking Induced Conversion)
45. Profil des principaux biomarqueurs du LCR des dégénérescences lobaires frontotemporales
46. Alzheimer’s Diseases: Towards Biomarkers for an Early Diagnosis
47. Impact of harmonization of collection tubes on Alzheimer's disease diagnosis
48. Interdisciplinary Case Study: Geochemistry Meets the Clinic in Search for a Metal ALS Biomarker
49. International initiative for harmonization of cerebrospinal fluid diagnostic comments in Alzheimer's disease
50. Severe Malaria with Neurological Manifestations: What Contribution of Neurofilament Light Chain?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.